AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT04853771 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: progressive muscle relaxation exercise training
Description: Progressive muscle relaxation exercises (PKGE); 16 large muscles (right hand and forearm, right upper arm, left hand and forearm of left arm, left upper arm, forehead, upper cheek and nose, chin, neck, abdomen, upper right arm, which people can do on their own after learning) leg, right calf, right foot, left upper leg, left thigh and left foot), followed by the contraction and then relaxation and accompanied by deep breathing, is a preferred method for reducing pain, anxiety and depression in individuals.The relaxation will be required to take 10-20 before stretching the next muscle group. In this way, the muscle groups in the hands, arms, neck, shoulder, chest, abdomen, hips, feet and fingers, face and the whole body will be voluntarily stretched and relaxed, and pregnant women will be relieved.
Study NCT05215314 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: mHealth Meditation
Description: Participants will receive access to the 4-week Healthy Minds Program (HMP) Foundations module. The HMP app is a meditation-based smartphone app designed to promote and protect psychological well-being through sustainable skills training. The program is grounded in constituents of psychological well-being identified in empirical literature. HMP provides core content, with instruction administered through a curriculum of guided practices. HMP is based on research on eudaimonic well-being (e.g., environmental mastery, purpose) and brain-based skills that underlie these qualities (e.g., regulation of attention, mental flexibility). The full HMP has guided audio practices that address 4 constituents of well-being: awareness, connection, insight, and purpose. At post-treatment, participants will be given access to additional HMP content to support their continued practice.
Study NCT05766293 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: extracorporeal shockwave device
Description: Fibroblast cell lines (n=10) were subjected to Shockwaves from extracorporeal shockwave device
Study NCT05140135 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Recovery Oriented Cognitive Therapy (CT-R)
Description: The CT-R that will be implemented in the present study will focus on strengthening aspirations and focusing on activities that can bring about one's desired life. In CT-R, clinicians use techniques to engage the patient in the adaptive mode, which includes cognitions, affects, motivation, and behaviors that are activated when the individual is engaged in personally meaningful activities.
Study NCT05140135 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Treatment as Usual
Description: All patients enrolled in the study who are randomized to the continued care as usual condition will continue to receive the treatments from their physician/treatment team at the Community Mental Health Center; however, they will not receive the adjunctive CT-R treatment.
Study NCT06349824 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: injection Dextrose water
Description: dextrose will be injected around median nerve in wrist
Study NCT06349824 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: USG machine
Description: usg guided nerve hydrdissection
Study NCT04880239 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Posterior colpoperineorrhaphy
Description: Patients having a sacralcolpopexy will be randomized to ultra lightweight mesh (Coloplast Restorelle) with posterior colpoperineorrhaphy or the same procedure without the posterior colpoperineorrhaphy
Study NCT03110484 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pemetrexed 500 MG
Description: Pemetrexed 500 mg/m2
Study NCT03110484 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Erlotinib
Description: Erlotinib 100mg once daily
Study NCT05638581 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: LTOWB
Description: Participants will receive Low Titer O Whole Blood administered intravenously or intraosseously.
Study NCT05638581 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: Components
Description: Participants will receive separated blood components (i.e., units of red cells, plasma, platelets, and cryoprecipitate) co-administered intravenously or intraosseously.
Study NCT06468566 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Ultrasound light scattering imaging equipment
Description: Radiologists use ultrasound light scattering imaging to evaluate the benign and malignant nature of breast nodules
Study NCT05766293 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Fibroblast cell lines not subjected to shockwaves from extracorporeal shockwave device
Description: Fibroblast cell lines (n=10) without shockwave exposure
Study NCT05806073 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Elective neck dissection
Description: patient underwent elective neck dissection(level I-III) as initial treatment, along with the excision of the primary tumor
Study NCT05806073 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Therapeutic neck dissection
Description: patient underwent Therapeutic neck dissection(level I-V) as initial treatment, along with the excision of the primary tumor
Study NCT05720273 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: palicalcitol
Description: This study does not interfere with the clinical medication of the researchers, and the usage and dosage of the drugs will be recorded according to the actual use. The recommended starting dose of palicalcitol may be based on body weight, baseline iPTH, or combined with prior medication. Dose adjustment should be determined according to pre-dialysis iPTH, Ca and P. iPTH levels should be maintained at 150-300pg/ml, while Ca and P levels should be closely monitored. If hypercalcemia occurs, the dose should be reduced or medication should be discontinued until these parameters return to normal; Subsequently, the dose of palicalcitol should be restarted at a lower dose. If PTH levels decrease as a result of treatment, the dose of medication may need to be reduced accordingly. The dose adjustment interval is 2-4 weeks, and the dose can be adjusted immediately for safety reasons.
Study NCT04749277 — intervention group
Intervention type: OTHER
Intervention: CAD EYE® (Fujifilm, Europe, Gesellschaft mit beschränkter Haftung, Dusseldorf, Germany)
Description: Methods plan~Phase 1. Brief virtual chromoendoscopy training on the characterization of colorectal polyps (WLI, LCI and BLI)~Phase 2. CAD EYE® system applied during colonoscopy retrieval:~2.1. CAD EYE® system OFF: Virtual chromoendoscopy (BLI) - independently characterization of a suspected polyp in WLI and BLI by the first endoscopist and by the second endoscopist (iconographic record) 2.2. CAD EYE® system ON: Characterization mode (BLI): Characterization of a suspected polyp by CAD EYE® and respectively level of characterization (1 to 3) (iconographic record) Phase 3. Histopathological evaluation (pathologist with gastrointestinal expertise): Resection and recovery of a suspected polyp for anatomopathological characterization
Study NCT05848180 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Ankle proprioceptive training (APT)
Description: APT comprise of exercises including towel curls, uni-leg stance on foam with activity, writing alphabets on gym ball with toes, picking marbles with toes.~BT includes tendem walk, side leg raises, sit to stand, side walk, back leg raise
Study NCT05848180 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Balance training (BT)
Description: Balance training exercises comprising of side walk, tandem walk, standing on one leg, walking with alternating arm raise up to 90 degrees
Study NCT05848180 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Balance training (BT)
Description: Balance training exercises comprising of side walk, tandem walk, standing on one leg, walking with alternating arm raise up to 90 degrees
Study NCT05892146 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Prevention therapy
Description: Sacubitril/Valsartan (25/80) mg twice a day for 1 year
Study NCT05892146 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Rescue therapy
Description: Sacubitril/Valsartan (25/80) mg twice a day for 1 year
Study NCT05355649 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: PREGNOLIA SYSTEM
Description: The Pregnolia System is composed of two products: an active device (Pregnolia Control Unit) and a single-use sterile probe (Pregnolia Probe).~The intended use of the Pregnolia System is to provide information about the mechanical properties of the uterine cervix by assessing the tissue stiffness through a proxy parameter (the closing pressure, denominated CSI, or Cervical Stiffness Index, in mbar). The Pregnolia System is intended to be used in conjunction with the information obtained from the clinical evaluation of the patient and in addition to other standard examinations.
Study NCT05294939 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Ketone monoester
Description: Consumption of 800mg/kg body weight of ketone monoester, divided in two intakes. The mixture will be prepared with bicarbonate. In addition, every hour they should consume 90g of carbohydrates.
Study NCT05294939 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Control product consumption
Description: Consumption of placebo product (carbohydrates) masked with citric, divided in two intakes. The mixture will be prepared with bicarbonate. In addition, 90g of carbohydrates should be consumed every hour.
Study NCT05363488 — intervention group
Intervention type: DRUG
Intervention: Bosutinib
Description: Patients receiving bosutinib treatment
Study NCT04794738 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SHR8554
Description: SHR8554 Injection; high dose
Study NCT04794738 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SHR8554
Description: SHR8554 Injection; low dose
Study NCT04794738 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Saline Solution
Description: Saline Solution
Study NCT04794738 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Morphine
Description: Morphine
Study NCT05865951 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Isometric Exercises
Description: Isometric (same length) strengthening exercises of the neck muscles will be performed.
Study NCT05865951 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Isotonic Exercises
Description: Isotonic strengthening exercises for the neck muscles will be performed.
Study NCT04614844 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Simulation Intervention
Description: Participants randomized to the intervention arm will receive CRI:SIS as a three-hour simulation session.
Study NCT04614844 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Control
Description: Participants randomized to the control arm will participate in four shift data collections, with no additional intervention.
Study NCT05221008 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SHR6508；Placebo
Description: Group A:SHR6508 low dose
Study NCT05221008 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SHR6508；Placebo
Description: Group B:SHR6508 medium dose
Study NCT05221008 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SHR6508；Placebo
Description: Group C:SHR6508 high dose
Study NCT05221008 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SHR6508；Placebo
Description: Group D:SHR6508 high dose(single dose)
Study NCT05370794 — intervention group
Intervention type: DRUG
Intervention: rhCG= Ovitrelle®, 250g/0.5ml = 26000IU/ml, Merck-Serono
Description: recombinant hCG
Study NCT05370794 — intervention group
Intervention type: DRUG
Intervention: rFSH = Gonal F®, 300IU/0.5ml, Merck-Serono
Description: recombinant FSH
Study NCT05760235 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Endoscopic sleeve gastroplasty (ESG)
Description: ESG will be performed under general anaesthesia with orotracheal intubation. The Endomina® suturing system (EndoTools Therapeutics S.A., Gosselies, Belgium) mounted on a single channel endoscope will be used. This system allows to obtain full thickness gastric sutures through the gastric wall of the gastric body, leaving the antrum and the gastric fundus free15. The procedure will be performed with the patient in supine position. Carbon dioxide will be blown to stretch the gastric lumen. An initial endoscopic evaluation will be performed immediately to confirm the absence of any contraindication to ESG before suturing. The ESG starts with the reduction of the gastric body, suturing from distal to proximal and starting from the notch of the angulus and ending at the level of the fundus. 4-8 full thickness stitches will be placed, with 2 passes per stitch.
Study NCT05484843 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: telenursing training based on self-care theory
Description: * A training guide based on the self-care theory specific to individuals diagnosed with stroke was prepared.~* Identification of the study/control group (randomization)~* Patients were informed and consents were obtained.~* Sample suitability was evaluated in line with the cognitive levels and inclusion criteria of patients diagnosed with stroke.~* All patients included in the sample group were pre-tested before discharge.~* Training was offered for the study group patients in line with the guide prepared based on self-care theory.~* Tele-nursing training was applied to the study group patients.~* Control group patients were followed up~* Post-tests were administered at the end of the 12-week period~* The training of the control group patients was completed~* Your data has been evaluated
Study NCT05484843 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: just observation
Description: For 3 months, patients were observed without intervention. The standard discharge training of the clinic was given.
Study NCT05386082 — intervention group
Intervention type: OTHER
Intervention: Modified Delphi process
Description: The study involves a brief demographics survey and Delphi process, i.e. three rounds of information and surveys, in which participants will be asked to score/rank potential metrics.
Study NCT06483542 — intervention group
Intervention type: OTHER
Intervention: bioenergetic balance
Description: Bioenergetic balance is calculated for all patients who had a resting energy expenditure measurement with indirect calorimetry.
Study NCT05832528 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Low-FODMAP diet
Description: 6-week Low-FODMAP diet in patients with functional dyspepsia
Study NCT05174117 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: single irradiation
Description: 46-48h irradiation after photosensitizer injection: power density: 200mW·cm-2, irradiation time: 900s, volume density: 180 J·cm-2
Study NCT05174117 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: ACTIVE_COMPARATOR
Intervention: Double irradiation
Description: 46-48h, 72h after photosensitizer injection, divided into two irradiation times: power density: 200mW·cm-2, irradiation time: 900s, volume density: 180 J·cm-2;Power density: 200mW·cm-2, irradiation time: 300s, volume density: 60 J·cm-2.
Study NCT06000592 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Digitimer
Description: transcutaneous spinal cord stimulation for blood pressure control following spinal cord injury.
Study NCT05480176 — intervention group
Intervention type: OTHER
Intervention: Comprehensive intervention and management Ⅰ
Description: Mainly health advisory.
Study NCT05480176 — intervention group
Intervention type: OTHER
Intervention: Comprehensive intervention and management Ⅱ
Description: Health advisory and regular follow-ups.
Study NCT05480176 — intervention group
Intervention type: OTHER
Intervention: Comprehensive intervention and management Ⅲ
Description: Pharmaceutical and non-pharmaceutical (e.g. health advisory, rehabilitation, etc.) interventions according to standardized clinical guidelines, with regular follow-ups.
Study NCT05068986 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Asthma education
Description: All the study participants were subjected to an educational asthma program for 3 months for providing parents and children with information and skills to manage their asthma ,which was presented from the the first session, through providing a written asthma action plan, information about avoiding triggers, training in the correct use of medicines, including inhaler technique, information and support to maximize adherence . All patients were followed up by a phone call every 2 weeks and follow up visit monthly to confirm compliance to the educational program
Study NCT04748939 — intervention group
Intervention type: BIOLOGICAL
Group type: PLACEBO_COMPARATOR
Intervention: recombinant subunit herpes zoster vaccine
Description: vaccine administration
Study NCT04748939 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: recombinant subunit herpes zoster vaccine
Description: vaccine administration
Study NCT04531592 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Valproic acid
Description: Valproate sodium in 5-ml single-dose vials containing 100 mg/ml of VPA. The appropriate dose of 140 mg/kg, based on the subject's weight at study entry, will be diluted in isotonic saline solution to a final volume of 300 ml for administration
Study NCT04531592 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Isotonic saline solution
Description: Isotonic saline solution consisting of 0.9% sodium chloride in the volume of 300 ml for administration
Study NCT05293548 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Recombinant COVID-19 Vaccine (CHO cell，NVSI-06-09)
Description: Intramuscular injection of Recombinant COVID-19 Vaccine (CHO cell，NVSI-06-09) in the deltoid muscle of the upper arm
Study NCT05293548 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: Inactivated COVID-19 vaccine (Vero cells)
Description: Biological/Vaccine: Inactivated COVID-19 vaccine (Vero cells) Intramuscular injection of Inactivated COVID-19 vaccine (Vero cells) in the deltoid muscle of the upper arm
Study NCT06301308 — intervention group
Intervention type: DRUG
Group type: SHAM_COMPARATOR
Intervention: Intraurethral lidocaine gel alone
Description: participants received 10 ml of intraurethral lidocaine gel at a concentration of 2%
Study NCT06301308 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Intraurethral lidocaine gel + lidocaine 2% injection
Description: participants received 10 ml of intraurethral lidocaine gel at a concentration of 2% and using the injection of lidocaine 2% to irrigate the urethra using a 20 ml syringe.
Study NCT06301308 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: intraurethral lidocaine gel + liquid paraffinl
Description: Liquid paraffin were used to lubricate hte cystoscopy tube AND participants received 10 ml of intraurethral lidocaine gel at a concentration of 2%
Study NCT05680493 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Manual pressure release
Description: lengthens the muscle up to the increasing resistance, then gradually applies gentle pressure on MTrp until fingers feels a definite increase in tissue resistance (first barrier). Pressure would maintain until clinician sense relief of tension
Study NCT05680493 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Dry needling
Description: A filiform needle is inserted at 45 degree in to trigger point and then twirl the needle up and down to release trigger point
Study NCT05680493 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Heat therapy
Description: Hydro collator pack will be placed on affected area for relaxation and pain relief for 15 min
Study NCT05680493 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Heat therapy
Description: Hydro collator pack will be placed on affected area for relaxation and pain relief for 15 min
Study NCT06031298 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Dentin Graft
Description: Dentin graft is a grafting technique of autogenous origin that uses the teeth extracted from the patient for the graft material preparation.
Study NCT06031298 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: Dentin Graft
Description: Dentin graft is a grafting technique of autogenous origin that uses the teeth extracted from the patient for the graft material preparation.
Study NCT06447740 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Dopamine
Description: A bolus dose of 50μg/kg dopamine via renal artery to induce hyperemic status
Study NCT06447740 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Dopamine
Description: A bolus dose of 50μg/kg dopamine via renal artery to induce hyperemic status
Study NCT06447740 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dopamine
Description: A bolus dose of 50μg/kg dopamine via renal artery to induce hyperemic status
Study NCT06447740 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: PLACEBO_COMPARATOR
Intervention: Fractional Flow Reserve, Renal
Description: Renal FFR will be measured based on SOP
Study NCT06447740 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: Fractional Flow Reserve, Renal
Description: Renal FFR will be measured based on SOP
Study NCT06447740 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Fractional Flow Reserve, Renal
Description: Renal FFR will be measured based on SOP
Study NCT06447740 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Renal artery stenting
Description: Renal artery stenting will be implanted based on the protocol
Study NCT04455828 — intervention group
Intervention type: DEVICE
Intervention: WHOOP strap 3.0
Description: WHOOP strap 3.0, a photodiode-based device that tracks heart rate, respiratory rate, sleep, and heart rate variability.
Study NCT05067205 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Carpal tunnel release surgery
Description: Preoperative, 3 days, 2 weeks, 4 weeks and 24 weeks postoperatively